Business Context and Reporting Period
Company: HealthSouth Corporation (Note: The filing identifies the registrant as HealthSouth Corporation, despite the user metadata referencing "Encompass Health Corp," which was the name adopted later in 2003).
Reporting Period: Fiscal year ended December 31, 2001.
Business Overview: HealthSouth is the nation's largest provider of outpatient surgery, outpatient diagnostic, and rehabilitative healthcare services. As of December 31, 2001, the company operated approximately 1,900 locations across all 50 U.S. states, Puerto Rico, the United Kingdom, Canada, and Australia. The company operates through two primary segments: Inpatient and Other Clinical Services (rehabilitation hospitals and medical centers) and Outpatient Services (rehabilitation, surgery, and diagnostic centers).
Key Financial Metrics
| Metric | 2001 | 2000 |
|---|---|---|
| Revenues | $4,380,477,000 | $4,195,115,000 |
| Net Income | $202,387,000 | $278,465,000 |
| Earnings Per Share (Diluted) | $0.51 | $0.71 |
| Operating Cash Flow | $670,394,000 | $796,764,000 |
| Working Capital | $1,377,459,000 | $1,048,204,000 |
| Cash and Marketable Securities | $278,456,000 | $180,407,000 |
| Total Assets | $7,579,237,000 | $7,380,440,000 |
| Long-Term Debt | $3,026,947,000 | $3,211,829,000 |
| Stockholders' Equity | $3,796,924,000 | $3,526,454,000 |
Margins: Operating unit expenses were 66.3% of revenues in 2001, compared to 67.1% in 2000. Total operating expenses were 70.1% of revenues in 2001, compared to 70.7% in 2000.
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 4.4% to $4.38 billion, driven primarily by increased patient volume. Same-store revenues increased 7.3%.
- Profitability Decline: Net income decreased 27.3% to $202.4 million. This decline was significantly impacted by non-recurring charges totaling approximately $174.1 million related to the loss on the sale of assets.
- Asset Divestitures: The company sold non-strategic assets, including occupational medicine operations, a medical center in Richmond, Virginia, UK diagnostic operations, and four inpatient rehabilitation facilities. These sales generated net cash proceeds of approximately $215.4 million but resulted in significant losses on sale of assets.
- Debt Reduction: Long-term debt decreased by approximately $185 million due to net principal payments of $187.5 million, despite the issuance of new senior notes totaling $900 million during the year to refinance existing credit facilities.
- Reimbursement Mix: Medicare revenue increased to 31.1% of total revenues (from 29.0% in 2000), while commercial revenue decreased slightly to 42.6%.
Guidance, Outlook, Risks, and Unusual Items
Unusual Items
- Loss on Sale of Assets: A net loss of $174.1 million was recorded in 2001, comprising $139.9 million from the sale of the Richmond medical center and occupational medicine operations, $18.8 million from the sale of UK diagnostic and inpatient facilities, and $15.4 million from a sale-leaseback transaction.
- Legal Settlement: A non-recurring expense of $8.2 million was recorded related to a settlement with the U.S. Department of Justice regarding Medicare cost reporting.
- Credit Facility Termination: A loss of $6.5 million was recorded for the write-off of unamortized loan fees on a terminated credit facility.
Outlook and Strategy
Management intends to focus on enhancing profit margins through operating efficiencies and organic growth. The company plans to spend approximately $100 million to $150 million on maintenance and expansion and $250 million to $350 million on development activities over the next twelve months. The company is transitioning inpatient rehabilitation reimbursement from a cost-based system to a Prospective Payment System (PPS) effective January 1, 2002, which management believes will have a positive effect on results.
Risks and Contingencies
- Regulatory and Reimbursement Risk: The company is heavily dependent on third-party payors (31.1% Medicare, 2.6% Medicaid, 66.3% commercial). Changes in reimbursement rates or the implementation of PPS could materially affect financial results.
- Legal Proceedings: The company is subject to securities litigation filed in 1998 alleging misrepresentation of financial condition. Additionally, the Department of Justice intervened in a False Claims Act lawsuit regarding physical therapy practices; the company expects to vigorously defend these claims.
- Accounting Changes: The company adopted SFAS No. 142 (Goodwill and Other Intangibles) on January 1, 2002, which requires periodic impairment testing rather than amortization of goodwill, potentially impacting future reported results.
Investor Verification Checklist
- Asset Sales Impact: Verify the long-term strategic impact of divesting the Richmond medical center and UK operations on future revenue streams.
- PPS Transition: Monitor the actual financial impact of the Medicare Prospective Payment System (PPS) implementation for inpatient rehabilitation starting in 2002.
- Legal Exposure: Track the status of the Department of Justice False Claims Act intervention and the ongoing securities class action litigation.
- Debt Structure: Review the terms of the new senior notes issued in 2001 and the company's ability to service its $3 billion debt load given the decline in net income.
- Goodwill Impairment: Assess the potential for future goodwill impairment charges under the new SFAS No. 142 standard adopted in 2002.